Previous Close 0.00
Price To book 0.00
Short Ratio 0.00
Av. Daily Volume 0
NewsSee all news
SEC filingsSee all SEC filings
Drug catalyst information is displayed when you hover over the stage bar graph.
- Biotech Stock Roundup: Biogen Gains on Strong Q1, NASH Data on Gilead Drug
- Gilead (GILD) Q1 Earnings: Stock Likely to Beat Estimates?
- Gilead Sciences: NASH Bridges…To What?
- 3 Stocks Could Double Their Dividends -- But Shouldn't
- America's 12 Most Charitable Companies
- Better Buy: Gilead Sciences vs. Celgene
- Gilead Sciences: Know Hope…or No Hope?
- Is Pain Ahead for Healthcare ETFs After Weak JNJ Q1?
- 11 Most Profitable Companies In The Fortune 500
- Should Gilead Sciences Be Worried About Allergan?
- Why Now Is Not the Time to Buy Valeant Pharmaceuticals
- Gilead Sciences: Just Like Thermopylae?
- Should Gilead Sciences Acquire NewLink Genetics?
- Gilead Announces Scientific Presentations Demonstrating Efficacy of Harvoni® (Ledipasvir/Sofosbuvir) in Special Patient Populations With HCV Infection
- 10 Reasons Merck Could Be the World's Most Perfect Stock
- 3 Reasons Gilead Sciences Is a Better Dividend Stock Than Johnson & Johnson
- Gilead Presents Proof-of-Concept Data for GS-0976 in Nonalcoholic Steatohepatitis (NASH) at The International Liver Congress™ 2017
- Gilead Presents Data at the International Liver Congress™ 2017 Supporting the Efficacy and Safety of Vemlidy in Patients with Chronic Hepatitis B After 96 Weeks, and Also After Switching From Viread
- Gilead to Present Clinical and Preclinical Data on Nonalcoholic Steatohepatitis (NASH) at The International Liver Congress™ 2017
- Gilead Sciences: Who's Frustrated Now?
- CT ORDER - Confidential treatment order 17759473
- DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material 17715801
- DEF 14A - Other definitive proxy statements 17715773
- 10-K - Annual report (Section 13 and 15(d), not S-K Item 405) 17641985
- 8-K - Current report 17625707
- SC 13G/A (Amend) - Statement of acquisition of beneficial ownership by individuals 17604630
- SC 13G/A (Amend) - Statement of acquisition of beneficial ownership by individuals 17596249
- NO ACT (Paper) - No Action Letter 20170124
- 8-K - Current report 17582661
- 8-K - Current report 17579017